课题基金 / 基金详情

Attempt for gene therapy of retrovirus-induced disease

Attempt for gene therapy of retrovirus-induced disease
逆转录病毒引起的疾病的基因治疗尝试
批准号:
09670219
负责人:
KITAGAWA Masanobu
金额:
$1.15万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

KITAGAWA Masanobu的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To develop the model for gene therapy of retrovirus-induced disease, Fv-4 resistance (Fv-4^r) gene which confers strong resistance against murine leukemia virus (MuLV)-infection to host has been introduced to Friend leukemia virus (FLV)-susceptible C3H mouse bone marrow cells.1) Bone marrow transplantation of Fv-4^r-transfected bone marrow cells to C3H hostAfter introducing Fv-4^r gene using SFFV vector system, C3H bone marrow cells were transplanted to supralethally irradiated C3H host to create bone marrow chimeras (Fv-4^r-G3H * C3H). Fv-4^r gene product was expressed on the cell surface of hematopoietic cells in these chimera mice. The intensity of expression varied from mouse to mouse most of which expressed ranging from 10% to 20% of the expression by the hematopoietic cells of genetically Fv-4^r-bearing C4W mouse.2) Development of gene induction system with high efficiencyBy selecting vector systems and culture conditions, we could generate Fv-4^r-C3H * C3H chimeras that exhibited Fv-4^r expression of more than 30% of C4W mouse.3) Trial experiment to test the resistance of these chimeras to FLV-infectionA few number of Fv-4^r-C3H * C3H chimeras with high expression of Fv-4^r (>30% of C4W) exhibited resistance against FLV inoculation of 1x103 PFU.However, all mice died after infection with lx 104 PFU of FLV.By using Fr-4^r-G3H * C3H chimeras with high expression of Fv-4^r which were successfully conducted in the latest experiments, we would be able to develop a better model system for retrovirus-induced disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kitagawa M et al.: "Overexpression of tumor necrosis factor(TNF)-α and interferon(IFN)-γ by bone marrow cells from patients with myelodysplastic syndromes" Leukemia. 11. 2049-2054 (1997)
Kitakawa M 等人:“骨髓增生异常综合征患者的骨髓细胞过度表达肿瘤坏死因子 (TNF)-α 和干扰素 (IFN)-γ”白血病。11. 2049-2054 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kitagawa M et al.: "Cell-free transmission of Fv-4 resistance gene product controlling Friend leukemia virus-induced leukemigenesis in mice" Leukemia. 11 Suppl 3. 230-232 (1997)
Kitakawa M 等人:“Fv-4 抗性基因产物的无细胞传递控制 Friend 白血病病毒诱导的小鼠白血病发生”白血病。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kitagawa M et al.: "Overexpression of tumor necrosis factor(TNF)-α and interferon(IFN)- γ by bone marrow cells from patients with myelodysplastic syndromes" Leukemia. 11. 2049-2054 (1997)
Kitakawa M 等人:“骨髓增生异常综合征患者的骨髓细胞过度表达肿瘤坏死因子 (TNF)-α 和干扰素 (IFN)-γ”白血病。11. 2049-2054 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kamisaku H, Kitazawa M.et al.: "Limoithig diansmission analysis of T-cell progenitors in the bone of thymic thymic lymphome-susceptible BIO and-resistant C3H mice after fractionated whole-body X-irradiation" Int.J.Radiat.Biol.72. 191-199 (1997)
Kamisaku H、Kitazawa M.等人:“分次全身 X 射线照射后胸腺淋巴瘤敏感 BIO 和耐药 C3H 小鼠骨中 T 细胞祖细胞的 Limoithig 释放分析” Int.J.Radiat.Biol
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    Development of novel therapeutic strategy against highly malignant tumors
    • 批准号:
      15K08394
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2015
    • 负责人:
      KITAGAWA Masanobu
    • 依托单位:
    Development of anti-tumor therapy model using MCM2 function
    • 批准号:
      24590476
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      KITAGAWA Masanobu
    • 依托单位:
    Development of novel therapeutic strategy against tumor progression using animal model
    • 批准号:
      21590432
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2009
    • 负责人:
      KITAGAWA Masanobu
    • 依托单位:
    Enhancement of radiation-induced apoptosis by retroviral infection : implication for the gene therapy
    • 批准号:
      14570180
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      2002
    • 负责人:
      KITAGAWA Masanobu
    • 依托单位: